Sandeep Nema, Ph.D.
About Sandeep Nema, Ph.D.
Sandeep Nema, Ph.D. Senior Vice President, Technical Operations
Sandeep Nema, Ph.D., holds the position of Senior Vice President of Technical Operations. His extensive experience spans over 24 years at Pfizer, where he played a crucial role in bringing innovative biologics products to various stages of development. His expertise is evident from his leadership in advancing Pfizer’s COVID-19 LNP-mRNA vaccine to the clinic and achieving emergency use authorization. Nema’s role involves significant responsibilities in overseeing pre-proof-of-concept projects, ensuring their progression from discovery to the brink of Phase 3 trials.
Sandeep Nema's Contributions to Pfizer
Throughout his tenure at Pfizer, Sandeep Nema made substantial contributions. He established the Protein Pharmaceutical R&D group that encapsulated critical functions such as Formulation, Microbiology, and Stability. His leadership was instrumental in progressing approximately 50 biologics projects from discovery through to the commencement of Phase 3 clinical trials. Notably, his team was pivotal in the successful clinical introduction and emergency use authorization of Pfizer’s COVID-19 LNP-mRNA vaccine, demonstrating his significant impact on public health and pharmaceutical innovation.
Sandeep Nema's Educational Background
Sandeep Nema earned his Ph.D. in Pharmaceuticals from the University of Tennessee Health Science Center. His academic foundation was built on a Bachelor of Pharmacy degree from Banaras Hindu University. This solid educational background has underpinned his career in pharmaceutical sciences and his subsequent contributions to the field. Nema is also a Certified Regulatory Affairs Professional, showcasing his comprehensive understanding of the regulatory landscape in pharmaceuticals.
Sandeep Nema, Adjunct Professor at University of Tennessee
In addition to his professional endeavors, Sandeep Nema serves as an adjunct Professor at the University of Tennessee. This role allows him to impart his extensive knowledge and experience in pharmaceuticals to the next generation of scientists and industry professionals. His academic involvement underlines his commitment to advancing the field through education and mentorship.